Page last updated: 2024-08-21

medroxyprogesterone and Genetic Predisposition

medroxyprogesterone has been researched along with Genetic Predisposition in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bray, PF; Herrington, DM; Howard, TD; Sane, DC; Vittinghoff, E1
Bilgen, T; Cetin, Z; Keser, I; Luleci, G; Simsek, M; Taskin, O1

Trials

1 trial(s) available for medroxyprogesterone and Genetic Predisposition

ArticleYear
Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy.
    Blood, 2007, Mar-01, Volume: 109, Issue:5

    Topics: Aged; Alleles; Coronary Disease; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Medroxyprogesterone; Membrane Glycoproteins; Membrane Proteins; Mutation; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Polymorphism, Genetic; Postmenopause; Risk Factors; Time Factors; Treatment Outcome

2007

Other Studies

1 other study(ies) available for medroxyprogesterone and Genetic Predisposition

ArticleYear
Effects of hormone replacement therapy on bone mineral density in Turkish patients with or without COL1A1 Sp1 binding site polymorphism.
    The journal of obstetrics and gynaecology research, 2008, Volume: 34, Issue:1

    Topics: Absorptiometry, Photon; Bone Density; Case-Control Studies; Collagen Type I; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Genetic Predisposition to Disease; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Sp1 Transcription Factor; Turkey; White People

2008